|
GNL3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.744510E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.501400E-03 |
| Normal-vs-Stage2 |
5.88769999999572E-05 |
| Normal-vs-Stage3 |
9.299000E-03 |
| Normal-vs-Stage4 |
9.638500E-02 |
| Stage1-vs-Stage2 |
1.751610E-02 |
| Stage1-vs-Stage3 |
5.515000E-01 |
| Stage1-vs-Stage4 |
7.404200E-01 |
| Stage2-vs-Stage3 |
9.324000E-02 |
| Stage2-vs-Stage4 |
1.943930E-02 |
| Stage3-vs-Stage4 |
4.832400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.355600E-03 |
| Normal-vs-AfricanAmerican |
6.311700E-02 |
| Normal-vs-Asian |
6.939700E-02 |
| Caucasian-vs-AfricanAmerican |
8.254400E-01 |
| Caucasian-vs-Asian |
8.692600E-01 |
| AfricanAmerican-vs-Asian |
7.485400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.059200E-03 |
| Normal-vs-Female |
4.363000E-03 |
| Male-vs-Female |
3.796000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.302000E-02 |
| Normal-vs-Age(41-60Yrs) |
2.754500E-04 |
| Normal-vs-Age(61-80Yrs) |
2.135300E-03 |
| Normal-vs-Age(81-100Yrs) |
4.844000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.910100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.931600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.336000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.495200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.422500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.690300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.636800E-01 |
| Classical-VS-Follicular |
1.85359999571588E-08 |
| Classical-VS-Other |
3.600200E-01 |
| Classical-VS-Normal |
1.551570E-01 |
| Tall-VS-Follicular |
5.205200E-04 |
| Tall-VS-Other |
2.956200E-01 |
| Tall-VS-Normal |
6.201800E-01 |
| Follicular-VS-Other |
3.906800E-01 |
| Follicular-VS-Normal |
9.16450000332247E-08 |
| Other-VS-Normal |
1.113400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.56058999999376E-05 |
| Normal-vs-N1 |
2.525800E-02 |
| N0-vs-N1 |
2.200200E-01 |
|
|
